9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Pfizer
Carevive Systems, Inc.
Adela, Inc
Massive Bio, Inc.
Tempus AI
Taproot Health
Sanguine Biosciences
Global BioClinical
Blue Note Therapeutics
Pfizer
Celgene
LEO Pharma
Shenzhen BinDeBio Ltd.
Novartis
Novartis
Novartis
Amgen